Nu-Med Plus (NUMD) EBITDA (2012 - 2025)
Nu-Med Plus recorded quarterly EBITDA of -$9761.0 in Q4 2025, up 3.12% quarter-over-quarter from -$10075.0 in Q3 2025, and down 5.02% year-over-year from -$10277.4 in Q4 2024.
Nu-Med Plus' EBITDA history runs 14 years deep, the most recent figure standing at -$9761.0 for Q4 2025.
- In Q4 2025, EBITDA fell 5.02% year-over-year to -$9761.0; the TTM figure through Dec 2025 stood at -$48955.0 (up 22.7% YoY), while the FY2025 annual figure was -$48955.0, up 22.7% from the prior year.
- EBITDA came in at -$9761.0 for Q4 2025 at Nu-Med Plus, up from -$10075.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$6394.0 in Q4 2022 to a low of -$354099.0 in Q1 2021.
- A 5-year average of -$62152.2 and a median of -$21826.0 in 2023 frame the typical range for EBITDA.
- Across the five-year window, EBITDA soared 94.17% in 2022 and sank 765.44% in 2023, its largest moves.
- Nu-Med Plus' EBITDA stood at -$109691.0 in 2021, then soared by 94.17% to -$6394.0 in 2022, then tumbled by 765.44% to -$55336.0 in 2023, then jumped by 83.2% to -$9294.0 in 2024, then decreased by 5.02% to -$9761.0 in 2025.
- According to Business Quant data, EBITDA over the past three periods registered -$9761.0, -$10075.0, and -$10419.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 663.81 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Nu-Med Plus | - | - | - | -9,761.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9,761.00 |
| Sep 30, 2025 | -10,075.00 |
| Jun 30, 2025 | -10,419.00 |
| Mar 31, 2025 | -18,700.00 |
| Dec 31, 2024 | -9,294.00 |
| Sep 30, 2024 | -17,417.00 |
| Jun 30, 2024 | -16,040.00 |
| Mar 31, 2024 | -20,579.00 |
| Dec 31, 2023 | -55,336.00 |
| Sep 30, 2023 | -15,146.00 |
| Jun 30, 2023 | -23,073.00 |
| Mar 31, 2023 | -26,971.00 |
| Dec 31, 2022 | -6,394.00 |
| Sep 30, 2022 | -58,050.00 |
| Jun 30, 2022 | -58,070.00 |
| Mar 31, 2022 | -57,638.00 |
| Dec 31, 2021 | -109,691.00 |
| Sep 30, 2021 | -115,717.00 |
| Jun 30, 2021 | -250,573.00 |
| Mar 31, 2021 | -354,099.00 |
| Dec 31, 2020 | -502,832.00 |
| Sep 30, 2020 | -446,710.00 |
| Jun 30, 2020 | -905,419.00 |
| Mar 31, 2020 | -146,265.00 |
| Dec 31, 2019 | -202,668.00 |
| Sep 30, 2019 | -143,079.00 |
| Jun 30, 2019 | -240,364.00 |
| Mar 31, 2019 | -419,953.00 |
| Dec 31, 2018 | -351,627.00 |
| Sep 30, 2018 | -518,488.00 |
| Jun 30, 2018 | -164,910.00 |
| Mar 31, 2018 | -138,978.00 |
| Dec 31, 2017 | 3.90 Mn |
| Sep 30, 2017 | -134,163.00 |
| Jun 30, 2017 | -107,718.00 |
| Mar 31, 2017 | -67,939.00 |
| Dec 31, 2016 | 941,239.00 |
| Sep 30, 2016 | -694,028.00 |
| Jun 30, 2016 | -176,176.00 |
| Mar 31, 2016 | -63,874.00 |
| Dec 31, 2015 | 813,056.00 |
| Sep 30, 2015 | -301,513.00 |
| Jun 30, 2015 | -387,504.00 |
| Mar 31, 2015 | -116,888.00 |
| Dec 31, 2014 | -528,127.00 |
| Sep 30, 2014 | -237,205.00 |
| Jun 30, 2014 | -196,570.00 |
| Mar 31, 2014 | -177,256.00 |
| Sep 30, 2013 | -87,000.00 |
| Jun 30, 2013 | -33,208.00 |
| Mar 31, 2013 | -79,817.00 |
| Dec 31, 2012 | -261,185.00 |
| Mar 31, 2012 | -19,542.00 |